4
Changes in Ownership
Trevi Therapeutics, Inc. Filed Acc 0001209191-23-038744
Chief Commercial Officer acquired 6,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Simon Farrell · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-20 | Exercise or conversion : show line 1 in the form | +6,250 | $0.51 | $3,194 | 45,650 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-06-20 | Exercise or conversion : show line 2 in the form Stock Option (right to buy) | −6,250 | 50,000 | D |
Loading xslF345X04/doc4.xml…